Literature DB >> 19881297

Sevoflurane postconditioning protects chronically-infarcted rat hearts against ischemia-reperfusion injury by activation of pro-survival kinases and inhibition of mitochondrial permeability transition pore opening upon reperfusion.

Yuntai Yao1, Lihuan Li, Libing Li, Changqing Gao, Chunxia Shi.   

Abstract

We evaluated the cardioprotection against myocardial ischemia-reperfusion injury induced by sevoflurane postconditioning (SpostC) in chronically-infarcted rat hearts, and investigated the roles of phosphoinositide 3-kinase (PI3K)-protein kinase B/Akt (PKB/Akt), mitogen-activated extracellular regulated kinase 1/2 (MEK 1/2)-extracellular regulated kinase 1/2 (ERK 1/2), and mitochondrial permeability transition pore (mPTP). Left anterior descending (LAD) coronary artery was ligated to induce myocardial infarction in rats. Six weeks later, chronically-infarcted hearts were isolated and subjected to 30 min of global ischemia, followed by 1 h of reperfusion with Krebs-Henseleit (K-H) buffer. SpostC was administered by perfusing the hearts with K-H buffer saturated with 3% sevoflurane during the first 15 min of reperfusion. To evaluate the role of PI3K-PKB/Akt and MEK 1/2-ERK 1/2 in SpostC, PI3K inhibitor LY294002 (15 microM) and MEK 1/2 inhibitor PD98059 (20 microM) were administered alone or together with sevoflurane during the first 15 min of reperfusion. We found that exposure of 3% sevoflurane during early reperfusion significantly improved functional recovery (improved left ventricular developed pressure (LVDP), +/-dp/dt, CF, HR and reduced left ventricular end-diastolic pressure (LVEDP)), decreased myocardial infarct size and reduced LDH and CK-MB release, when compared with unprotected hearts. However, these protective effects were abolished in the presence of either LY294002 or PD98059, which was accompanied by the prevention of PKB/Akt and ERK 1/2 phosphorylation, and reduction of myocardial nicotinamide adenine dinucleotide (NAD+) content. These findings suggest that sevoflurane postconditioning protects chronically-infarcted rat hearts against ischemia-reperfusion injury by inhibiting mPTP opening via recruitment of PKB/Akt and ERK 1/2.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19881297     DOI: 10.1248/bpb.32.1854

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  13 in total

1.  Ginsenoside Rb1 protects cardiomyocytes against CoCl2-induced apoptosis in neonatal rats by inhibiting mitochondria permeability transition pore opening.

Authors:  Hong-liang Kong; Zhan-quan Li; Ying-jun Zhao; Shu-mei Zhao; Li Zhu; Tong Li; Yao Fu; Hui-jun Li
Journal:  Acta Pharmacol Sin       Date:  2010-06       Impact factor: 6.150

2.  The effect of sevoflurane postconditioning on cardioprotection against ischemia-reperfusion injury in rabbits.

Authors:  Dong Chen; Bo Cheng; Hai-Yan Zhou; Li-Huan Li
Journal:  Mol Biol Rep       Date:  2012-01-07       Impact factor: 2.316

3.  Apelin-APJ effects of ginsenoside-Rb1 depending on hypoxia-induced factor 1α in hypoxia neonatal cardiomyocytes.

Authors:  Hong-liang Kong; Zhan-quan Li; Shu-mei Zhao; Long Yuan; Zhi-lin Miao; Ying Liu; Ru-ming Guan
Journal:  Chin J Integr Med       Date:  2014-06-03       Impact factor: 1.978

4.  Sevoflurane postconditioning attenuates cardiomyocyte hypoxia/reoxygenation injury via restoring mitochondrial morphology.

Authors:  Jin Yu; Jianjiang Wu; Peng Xie; Yiliyaer Maimaitili; Jiang Wang; Zhengyuan Xia; Feng Gao; Xing Zhang; Hong Zheng
Journal:  PeerJ       Date:  2016-11-03       Impact factor: 2.984

5.  Sevoflurane postconditioning protects the myocardium against ischemia/reperfusion injury via activation of the JAK2-STAT3 pathway.

Authors:  Jianjiang Wu; Jin Yu; Peng Xie; Yiliyaer Maimaitili; Jiang Wang; Long Yang; Haiping Ma; Xing Zhang; Yining Yang; Hong Zheng
Journal:  PeerJ       Date:  2017-04-04       Impact factor: 2.984

6.  Plin5 alleviates myocardial ischaemia/reperfusion injury by reducing oxidative stress through inhibiting the lipolysis of lipid droplets.

Authors:  Pengfei Zheng; Zhonglin Xie; Yuan Yuan; Wen Sui; Chao Wang; Xing Gao; Yuanlin Zhao; Feng Zhang; Yu Gu; Peizhen Hu; Jing Ye; Xuyang Feng; Lijun Zhang
Journal:  Sci Rep       Date:  2017-02-20       Impact factor: 4.379

Review 7.  Diabetes, perioperative ischaemia and volatile anaesthetics: consequences of derangements in myocardial substrate metabolism.

Authors:  Charissa E van den Brom; Carolien Se Bulte; Stephan A Loer; R Arthur Bouwman; Christa Boer
Journal:  Cardiovasc Diabetol       Date:  2013-03-04       Impact factor: 9.951

8.  Protective Effect of Sevoflurane Postconditioning against Cardiac Ischemia/Reperfusion Injury via Ameliorating Mitochondrial Impairment, Oxidative Stress and Rescuing Autophagic Clearance.

Authors:  Peng Yu; Jing Zhang; Shuchun Yu; Zhenzhong Luo; Fuzhou Hua; Linhui Yuan; Zhidong Zhou; Qin Liu; Xiaohong Du; Sisi Chen; Lieliang Zhang; Guohai Xu
Journal:  PLoS One       Date:  2015-08-11       Impact factor: 3.240

9.  Sevoflurane post-conditioning reduces rat myocardial ischemia reperfusion injury through an increase in NOS and a decrease in phopshorylated NHE1 levels.

Authors:  Jianfang Cao; Hong Xie; Ying Sun; Jiang Zhu; Ming Ying; Shigang Qiao; Qin Shao; Haorong Wu; Chen Wang
Journal:  Int J Mol Med       Date:  2015-10-12       Impact factor: 4.101

Review 10.  Mitochondria in Cardiac Postconditioning.

Authors:  Pasquale Pagliaro; Saveria Femminò; Jasmin Popara; Claudia Penna
Journal:  Front Physiol       Date:  2018-03-26       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.